Timothy Edwin Kelly - Mar 24, 2023 Form 4/A - Amendment Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Financial Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Stock symbol
PRAX
Transactions as of
Mar 24, 2023
Transactions value $
$6,998
Form type
4/A - Amendment
Date filed
4/6/2023, 05:43 PM
Date Of Original Report
Mar 27, 2023
Previous filing
Jan 13, 2023
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Purchase $7K +8K +20.82% $0.87 46.4K Mar 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.861 to $0.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Remarks:

This amended Form 4 is being filed to correct the code in column 4 of Table I to indicate that the shares were acquired.